Abstract
There are an increasing number of new drugs in the treatment of multiple sclerosis (MS). These new treatments along with the use of the older disease modifying drugs provide the neurologist with an increasing number of options in treatment of MS patients. These treatments have also contributed to the better understanding of the underlying immunopathology of the disease.
Author supplied keywords
Cite
CITATION STYLE
APA
Milonas, I. (2017, June 1). Advances in multiple sclerosis. European Neurological Review. Touch Briefings. https://doi.org/10.17925/ENR.2017.12.01.13
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free